Vector Science and Therapeutics Corp. (TSXV: PAIN)
Health Care · Biotechnology · US
CA$1.81
-16.97% today · +489.2% 1Y
Vector Science and Therapeutics Corp. (TSXV: PAIN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $245.64M.
Over the last twelve months the share price has gained 489.2%, trading between 0.35 and 2.65.
PAIN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $245.64M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.13
- Dividend yield
- —
- Beta (5Y)
- 4.65
- 52-week high
- CA$2.65
- 52-week low
- CA$0.35
- Avg volume (3M)
- —
- Shares outstanding
- 156.36M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.43 | +0.18% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.98 | +0.38% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.44 | +0.22% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.78 | +0.13% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $825.89 | -0.98% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $139.44 | -3.88% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.